Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 119

1.

Role of Vorapaxar After Coronary Revascularization.

Sharma A, Lavie CJ, Helft G, Chatterjee S, Goel S, Garg A, Mukherjee D, Marmur JD.

Am J Cardiol. 2016 Apr 1;117(7):1059-64. doi: 10.1016/j.amjcard.2015.12.051. Epub 2016 Jan 14.

PMID:
26851961
2.

The saga of the duration of dual antiplatelet therapy after drug-eluting stent placement.

Helft G.

Arch Cardiovasc Dis. 2015 Oct;108(10):469-71. doi: 10.1016/j.acvd.2015.09.001. Epub 2015 Oct 1. No abstract available.

PMID:
26432274
3.

Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trial.

Helft G, Steg PG, Le Feuvre C, Georges JL, Carrie D, Dreyfus X, Furber A, Leclercq F, Eltchaninoff H, Falquier JF, Henry P, Cattan S, Sebagh L, Michel PL, Tuambilangana A, Hammoudi N, Boccara F, Cayla G, Douard H, Diallo A, Berman E, Komajda M, Metzger JP, Vicaut E; OPTImal DUAL Antiplatelet Therapy Trial Investigators.

Eur Heart J. 2016 Jan 21;37(4):365-74. doi: 10.1093/eurheartj/ehv481. Epub 2015 Sep 12. Review.

PMID:
26364288
4.

Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.

Loncar G, Barthelemy O, Berman E, Kerneis M, Petroni T, Payot L, Choussat R, Silvain J, Collet JP, Helft G, Montalescot G, Le Feuvre C.

Arch Cardiovasc Dis. 2015 Nov;108(11):554-62. doi: 10.1016/j.acvd.2015.06.001. Epub 2015 Jul 13.

PMID:
26184868
5.

Outcomes of primary percutaneous coronary interventions in nonagenarians with acute myocardial infarction.

Helft G, Georges JL, Mouranche X, Loyeau A, Spaulding C, Caussin C, Benamer H, Garot P, Livarek B, Teiger E, Varenne O, Monségu J, Mapouata M, Petroni T, Hammoudi N, Lambert Y, Dupas F, Laborne F, Lapostolle F, Lefort H, Juliard JM, Letarnec JY, Lamhaut L, Lebail G, Boche T, Jouven X, Bataille S; e-MUST and CARDIO-ARSIF Registries.

Int J Cardiol. 2015 Aug 1;192:24-9. doi: 10.1016/j.ijcard.2015.04.227. Epub 2015 Apr 30.

PMID:
25985011
6.

Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Barthélémy O, Degrell P, Berman E, Kerneis M, Petroni T, Silvain J, Payot L, Choussat R, Collet JP, Helft G, Montalescot G, Le Feuvre C.

Arch Cardiovasc Dis. 2015 Aug-Sep;108(8-9):428-36. doi: 10.1016/j.acvd.2015.03.002. Epub 2015 Apr 27.

PMID:
25937358
7.

Prolonged dual antiplatelet therapy after drug-eluting stent reduces the risk of stent thrombosis and major cardiovascular events but increases the rate of bleeding.

Helft G.

Evid Based Med. 2015 Jun;20(3):99. doi: 10.1136/ebmed-2015-110167. Epub 2015 Mar 5. No abstract available.

PMID:
25743171
8.

The arranged marriage of cangrelor and bivalirudin.

Montalescot G, Helft G.

JACC Cardiovasc Interv. 2015 Mar;8(3):434-5. doi: 10.1016/j.jcin.2015.01.004. Epub 2015 Feb 18. No abstract available.

9.

Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians: a multicenter study.

Petroni T, Zaman A, Georges JL, Hammoudi N, Berman E, Segev A, Juliard JM, Barthelemy O, Silvain J, Choussat R, Le Feuvre C, Helft G.

J Am Geriatr Soc. 2015 Feb;63(2):384-6. doi: 10.1111/jgs.13264. No abstract available.

PMID:
25688612
10.

Effects of age and cardiovascular disease on selective attention.

Chokron S, Helft G, Perez C.

Cardiovasc Psychiatry Neurol. 2013;2013:185385. doi: 10.1155/2013/185385. Epub 2013 Dec 25.

11.

[Cardiovascular involvement in Behçet's disease].

Desbois AC, Wechsler B, Cluzel P, Helft G, Boutin D, Piette JC, Cacoub P, Saadoun D.

Rev Med Interne. 2014 Feb;35(2):103-11. doi: 10.1016/j.revmed.2013.12.002. Epub 2014 Jan 13. Review. French.

PMID:
24434015
12.

Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation.

Helft G.

Arch Cardiovasc Dis. 2013 May;106(5):271-3. doi: 10.1016/j.acvd.2013.03.060. Epub 2013 May 27. No abstract available.

13.

Efficacy and safety of 12 versus 48 months of dual antiplatelet therapy after implantation of a drug-eluting stent: the OPTImal DUAL antiplatelet therapy (OPTIDUAL) trial: study protocol for a randomized controlled trial.

Helft G, Le Feuvre C, Georges JL, Carrie D, Leclercq F, Eltchaninoff H, Furber A, Prunier F, Sebagh L, Cattan S, Cayla G, Vicaut E, Metzger JP.

Trials. 2013 Feb 21;14:56. doi: 10.1186/1745-6215-14-56.

14.

Diagnostic performance of computed tomography coronary angiography (from the Prospective National Multicenter Multivendor EVASCAN Study).

Gueret P, Deux JF, Bonello L, Sarran A, Tron C, Christiaens L, Dacher JN, Bertrand D, Leborgne L, Renard C, Caussin C, Cluzel P, Helft G, Crochet D, Vernhet-Kovacsik H, Chabbert V, Ferrari E, Gilard M, Willoteaux S, Furber A, Barone-Rochette G, Jankowski A, Douek P, Mousseaux E, Sirol M, Niarra R, Chatellier G, Laissy JP.

Am J Cardiol. 2013 Feb 15;111(4):471-8. doi: 10.1016/j.amjcard.2012.10.029. Epub 2012 Dec 19.

PMID:
23261002
15.

Fractional flow reserve-guided PCI in stable coronary disease.

Helft G, Choussat R, Zaman A.

N Engl J Med. 2012 Dec 13;367(24):2355-6; author reply 2356. doi: 10.1056/NEJMc1212344#SA2. No abstract available.

PMID:
23234521
16.

Multislice computed tomography to rule out coronary allograft vasculopathy in heart transplant patients.

Barthélémy O, Toledano D, Varnous S, Fernandez F, Boutekadjirt R, Ricci F, Helft G, Le Feuvre C, Gandjbakhch I, Metzger JP, Pavie A, Cluzel P.

J Heart Lung Transplant. 2012 Dec;31(12):1262-8. doi: 10.1016/j.healun.2012.09.008.

PMID:
23206984
17.

Accuracy of multislice computed tomography in the preoperative assessment of coronary disease in patients scheduled for heart valve surgery.

Jakamy R, Barthélémy O, Le Feuvre C, Berman E, Boutekadjirt R, Cluzel P, Metzger JP, Helft G.

Arch Cardiovasc Dis. 2012 Aug-Sep;105(8-9):424-31. doi: 10.1016/j.acvd.2012.05.004. Epub 2012 Jul 17.

18.

Brain perfusion SPECT imaging and acetazolamide challenge in vascular cognitive impairment.

Farid K, Petras S, Ducasse V, Chokron S, Helft G, Blacher J, Caillat-Vigneron N.

Nucl Med Commun. 2012 Jun;33(6):571-80. doi: 10.1097/MNM.0b013e328351d583. Review.

PMID:
22495081
19.

One-year clinical outcomes in patients with chronic renal failure treated by percutaneous coronary intervention with drug-eluting stent.

Barthelemy O, Helft G, Silvain J, Bellemain-Appaix A, Beygui F, Choussat R, Berman E, Collet JP, Montalescot G, Metzger JP, Le Feuvre C.

Arch Cardiovasc Dis. 2011 Dec;104(12):604-10. doi: 10.1016/j.acvd.2011.05.010. Epub 2011 Nov 25.

20.

Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology.

Steg PG, Huber K, Andreotti F, Arnesen H, Atar D, Badimon L, Bassand JP, De Caterina R, Eikelboom JA, Gulba D, Hamon M, Helft G, Fox KA, Kristensen SD, Rao SV, Verheugt FW, Widimsky P, Zeymer U, Collet JP.

Eur Heart J. 2011 Aug;32(15):1854-64. doi: 10.1093/eurheartj/ehr204. Epub 2011 Jun 29.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk